San Diego, CA -- (SBWIRE) -- 06/27/2017 -- An investors in shares of TherapeuticsMD Inc (NYSEMKT:TXMD) filed a lawsuit against certain directors of TherapeuticsMD Inc over alleged breaches of fiduciary duties.

Investors who are current long term investors in TherapeuticsMD Inc (NYSEMKT:TXMD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The plaintiff alleges that certain officers and directors of TherapeuticsMD Inc breach of fiduciary duty and wasted of corporate assets. The lawsuit against certain directors of TherapeuticsMD Inc over alleged breaches of fiduciary duties follows a lawsuit filed against TherapeuticsMD Inc over alleged securities laws violations. According to that complaint filed the plaintiff alleges that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between July 7, 2016 and April 9, 2017, TherapeuticsMD made false and/or misleading statements and/or failed to disclose that: the Company's New Drug Application (NDA) submission for TX-004HR was deficient, that the NDA submission for TX-004HR was not supported by the complete TX-004HR clinical program and/or the clinical program was deficient, and that the deficient NDA would likely cause a delay of the FDA's potential approval of the TX-0004HR NDA.

Those who purchased shares of TherapeuticsMD have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com